Opioid Training Now Required for All DEA-Registered Providers 

The US Drug Enforcement Administration (DEA) issued a letter outlining the training that will meet the requirements of the Medication Access and Training Expansion (MATE) Act that was passed as part of the Consolidated Appropriations Act of 2023.

The letter also states that, effective June 27, 2023, physicians will be able to simply check a box on their DEA registration application or renewal form indicating that they have satisfied this training requirement.

The new DEA letter appears to be largely consistent with the recommendations that the American Medical Association (AMA) made to the DEA in a letter earlier this month. The AMA letter notes, the AMA Ed Hub has multiple offerings “on the treatment and management of patients with opioid or other substance use disorders,” which are included in the AMA's Opioid Therapy and Pain Management CME course. Using the new DEA guidance, the AMA is thoroughly reviewing these materials to determine which ones to include in a dedicated web page that will soon be created to help physicians and other practitioners satisfy the one-time, eight-hour training requirement.

Below is a list of places ACMS shared (in addition to the AMA resources link above - also in the IMA April 1st WIRE newsletter) to access this training.